Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
CALL
Philip Morris
PM
$298B
| $26M | 0.01% |
266,700
-537,500
| -67% | -$51.4M |
|
|
DICE
1152
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $26M | 0.01% |
560,358
+288,784
| +106% | +$9.98M |
|
1153
CALL
General Dynamics
GD
$104B
| $26M | 0.01% |
120,900
-55,100
| -31% | -$11.9M |
|
1154
PUT
Diamondback Energy
FANG
$57.6B
| $26M | 0.01% |
197,800
-18,700
| -9% | -$2.5M |
|
1155
WEX
WEX
$6.93B
| $26M | 0.01% |
142,553
-14,129
| -9% | -$2.5M |
|
1156
Liberty Global Class A
LBTYA
$3.66B
| $25.9M | 0.01% |
1,538,996
+903,845
| +142% | +$16.1M |
|
1157
Tanger
SKT
$4.47B
| $25.9M | 0.01% |
1,175,450
+415,446
| +55% | +$8.33M |
|
1158
Frontdoor
FTDR
$5.7B
| $25.9M | 0.01% |
813,047
+797,080
| +4,992% | +$23.7M |
|
1159
Gentex
GNTX
$4.97B
| $25.9M | 0.01% |
885,933
+42,302
| +5% | +$1.17M |
|
1160
Blackstone Secured Lending
BXSL
$5.82B
| $25.9M | 0.01% |
947,160
+473,417
| +100% | +$12.2M |
|
1161
Hyatt Hotels
H
$17B
| $25.8M | 0.01% |
225,598
+40,222
| +22% | +$4.55M |
|
1162
Patterson-UTI
PTEN
$4.52B
| $25.8M | 0.01% |
2,154,226
-2,947,263
| -58% | -$33.3M |
|
1163
Lennar Class A
LEN
$21.2B
| $25.8M | 0.01% |
212,467
+2,622
| +1% | +$286K |
|
1164
Smith & Nephew
SNN
$12.4B
| $25.7M | 0.01% |
798,190
+788,501
| +8,138% | +$24.4M |
|
|
UNVR
1165
DELISTED
Univar Solutions Inc.
UNVR
| $25.7M | 0.01% |
717,764
+219,147
| +44% | +$7.78M |
|
1166
Tandem Diabetes Care
TNDM
$1.55B
| $25.7M | 0.01% |
1,047,385
+752,481
| +255% | +$24.2M |
|
1167
Ares Capital
ARCC
$14.4B
| $25.7M | 0.01% |
1,367,813
-386,186
| -22% | -$7.13M |
|
|
PLMJ
1168
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
| $25.7M | 0.01% |
2,475,000
| – | – |
|
1169
PUT
Danaher
DHR
$151B
| $25.6M | 0.01% |
120,358
-175,968
| -59% | -$37.3M |
|
1170
CALL
Analog Devices
ADI
$181B
| $25.6M | 0.01% |
131,400
+37,500
| +40% | +$6.94M |
|
1171
CALL
Southwest Airlines
LUV
$19.9B
| $25.6M | 0.01% |
706,100
+151,900
| +27% | +$4.76M |
|
1172
JD.com
JD
$39.4B
| $25.5M | 0.01% |
748,297
+506,948
| +210% | +$18.4M |
|
|
EXAS
1173
DELISTED
Exact Sciences
EXAS
| $25.5M | 0.01% |
271,941
-252,478
| -48% | -$19.7M |
|
1174
Arcosa
ACA
$7.13B
| $25.5M | 0.01% |
336,922
+259,117
| +333% | +$17.4M |
|
1175
Kite Realty
KRG
$5.26B
| $25.5M | 0.01% |
1,142,680
-134,966
| -11% | -$2.78M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.